Literature DB >> 31919534

[Radiological diagnostic workup of liver tumors].

H-J Raatschen1.   

Abstract

The imaging of focal liver lesions is a common task in daily radiological routine. The objectives of diagnostic imaging are, in addition to lesion detection, the characterization of the lesion as well as the follow-up assessment after surgical or local treatment or under systemic therapy. This article presents the typical morphologies observed in computed tomography and magnetic resonance imaging of hepatocellular carcinomas and intrahepatic cholangiocarcinomas as the most important representatives of primary malignant liver tumors and juxtaposes them with benign primary liver lesions such as adenoma and focal nodular hyperplasia (FNH). In addition, relevant technical aspects of imaging are briefly summarized. Finally, the main and additional criteria of the Liver Imaging Reporting and Data System (LI-RADS®) classification, which are becoming increasingly established clinically for the evaluation of liver lesions in the cirrhotic liver, are presented.

Entities:  

Keywords:  Adenoma, liver cell; Carcinoma, hepatocellular; Cholangiocellular carcinoma, intrahepatic; Focal nodular hyperplasia; Liver cirrhosis

Mesh:

Year:  2020        PMID: 31919534     DOI: 10.1007/s00108-019-00724-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  19 in total

1.  Intrahepatic cholangiocarcinoma: MR appearance.

Authors:  J Hamrick-Turner; P L Abbitt; P R Ros
Journal:  AJR Am J Roentgenol       Date:  1992-01       Impact factor: 3.959

2.  Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.

Authors:  Mi-Suk Park; Sooah Kim; Jignesh Patel; Cristina H Hajdu; Richard K G Do; Lorenzo Mannelli; James S Babb; Bachir Taouli
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

3.  LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.

Authors:  Donald G Mitchell; Jordi Bruix; Morris Sherman; Claude B Sirlin
Journal:  Hepatology       Date:  2014-12-12       Impact factor: 17.425

4.  Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?

Authors:  Kristina Imeen Ringe; Frank Wacker; Hans-Jürgen Raatschen
Journal:  Acta Radiol       Date:  2014-01-20       Impact factor: 1.990

5.  Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver.

Authors:  Riccardo Inchingolo; Anna Maria De Gaetano; Davide Curione; Marzia Ciresa; Luca Miele; Maurizio Pompili; Fabio Maria Vecchio; Felice Giuliante; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2014-11-28       Impact factor: 5.315

6.  Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Authors:  Peng-Ju Xu; Fu-Hua Yan; Jian-Hua Wang; Yan Shan; Yuan Ji; Cai-Zhong Chen
Journal:  J Comput Assist Tomogr       Date:  2010-07       Impact factor: 1.826

Review 7.  Hepatic adenomas: imaging and pathologic findings.

Authors:  L Grazioli; M P Federle; G Brancatelli; T Ichikawa; L Olivetti; A Blachar
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

8.  Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging.

Authors:  Z M Fan; Y Yamashita; M Harada; Y Baba; H Yamamoto; T Matsukawa; A Arakawa; T Miyazaki; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

9.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Elmar M Merkle; Christoph J Zech; Carlo Bartolozzi; Mustafa R Bashir; Ahmed Ba-Ssalamah; Alexander Huppertz; Jeong Min Lee; Jens Ricke; Michiie Sakamoto; Claude B Sirlin; Sheng-Long Ye; Mengsu Zeng
Journal:  Eur Radiol       Date:  2015-06-13       Impact factor: 5.315

Review 10.  LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.

Authors:  Khaled M Elsayes; Ania Z Kielar; Victoria Chernyak; Ali Morshid; Alessandro Furlan; William R Masch; Robert M Marks; Aya Kamaya; Richard K G Do; Yuko Kono; Kathryn J Fowler; An Tang; Mustafa R Bashir; Elizabeth M Hecht; Kedar Jambhekar; Andrej Lyshchik; Shuchi K Rodgers; Jay P Heiken; Marc Kohli; David T Fetzer; Stephanie R Wilson; Zahra Kassam; Mishal Mendiratta-Lala; Amit G Singal; Christopher S Lim; Irene Cruite; James Lee; Ryan Ash; Donald G Mitchell; Matthew D F McInnes; Claude B Sirlin
Journal:  J Hepatocell Carcinoma       Date:  2019-02-05
View more
  1 in total

1.  A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

Authors:  Holger Moch; Alwin Krämer; Chantal Pauli; Tilmann Bochtler; Linda Mileshkin; Giulia Baciarello; Ferran Losa; Jeffrey S Ross; George Pentheroudakis; George Zarkavelis; Suayib Yalcin; Mustafa Özgüroğlu; Andreas Beringer; Jeremy Scarato; Mathis Mueller-Ohldach; Marlene Thomas
Journal:  Oncologist       Date:  2021-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.